Latest filing published 29 Nov 2012 for Targeted Medical Pharma, Inc., €6,365.
Insider track record
No signal scores available.
Amir Blachman: trading record in brief
Amir Blachman is a declared insider of Targeted Medical Pharma, Inc., with filings sourced from SEC (Form 4). Altogether 3 filings, all relating to 12 November 2012.
The filings describe grants, exercises and other transfers rather than trades on the open market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
Most recently, on 29 November 2012, the filings show an option exercise worth €6,365 in Targeted Medical Pharma, Inc. Typically, a trade is published a median of 17 days after it takes place. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Amir Blachman
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 2,396 shares@ US$3.38Common StockSEC:0001144204-12-065647:0
- 23,958 shares@ US$3.38Common StockSEC:0001144204-12-065647:1
- 54,986 shares@ US$5.00Common StockSEC:0001144204-12-065647:2
3 of 3 declarations
